Gene · 5641
Papers1,807
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,807
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutations in DARS2 result in global dysregulation of mRNA metabolism and splicing. | Sci Rep | 2023 | 37563224 | PubTator, text mining | PubMed |
| Lessons learned through the 20-year development of a national fatal drowning database in Australia. | BMC Public Health | 2023 | 37550757 | PubTator, text mining | PubMed |
| Nanomedicine in cancer therapy. | Signal Transduct Target Ther | 2023 | 37544972 | PubTator, text mining | PubMed |
| Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma. | Cell Death Dis | 2023 | 37532692 | PubTator, text mining | PubMed |
| Oxidative stress genes define two subtypes of triple-negative breast cancer with prognostic and therapeutic implications. | Front Genet | 2023 | 37519893 | PubTator, text mining | PubMed |
| GADD45A and GADD45B as Novel Biomarkers Associated with Chromatin Regulators in Renal Ischemia-Reperfusion Injury. | Int J Mol Sci | 2023 | 37511062 | PubTator, text mining | PubMed |
| S373P Mutation Stabilizes the Receptor-Binding Domain of the Spike Protein in Omicron and Promotes Binding. | JACS Au | 2023 | 37502147 | PubTator, text mining | PubMed |
| Uncovering ferroptosis in Parkinson's disease via bioinformatics and machine learning, and reversed deducing potential therapeutic natural products. | Front Genet | 2023 | 37485340 | PubTator, text mining | PubMed |
| Lysosomes, curcumin, and anti-tumor effects: how are they linked? | Front Pharmacol | 2023 | 37484013 | PubTator, text mining | PubMed |
| Genetic analysis of potential biomarkers and therapeutic targets associated with ferroptosis from bronchopulmonary dysplasia. | Medicine (Baltimore) | 2023 | 37478211 | PubTator, text mining | PubMed |
| Cathepsin B Is Not an Intrinsic Factor Related to Asparaginase Resistance of the Acute Lymphoblastic Leukemia REH Cell Line. | Int J Mol Sci | 2023 | 37446393 | PubTator, text mining | PubMed |
| Underlying mechanisms and clinical potential of circRNAs in glioblastoma. | Oncol Res | 2023 | 37415736 | PubTator, text mining | PubMed |
| Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. | Genes Dis | 2023 | 37397557 | PubTator, text mining | PubMed |
| Efficacy of DigiKnowItNews: Teen, a multimedia educational website for adolescents about pediatric clinical trials: study protocol for a randomized controlled trial. | Trials | 2023 | 37391773 | PubTator, text mining | PubMed |
| Small Molecule Inhibitors as Therapeutic Agents Targeting Oncogenic Fusion Proteins: Current Status and Clinical. | Molecules | 2023 | 37375228 | PubTator, text mining | PubMed |
| Roles of Cysteine Proteases in Biology and Pathogenesis of Parasites. | Microorganisms | 2023 | 37374899 | PubTator, text mining | PubMed |
| Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade. | Nat Commun | 2023 | 37369658 | PubTator, text mining | PubMed |
| Spinal cord injury: molecular mechanisms and therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37357239 | PubTator, text mining | PubMed |
| Implementation determinants of HIV Self-Testing among young sexual minority men. | Arch Public Health | 2023 | 37344899 | PubTator, text mining | PubMed |
| Areas of enduring COVID-19 prevalence: drivers of prevalence and mitigating strategies. | BMC Public Health | 2023 | 37344781 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5641/papers?page=13